2023 Incentive Grant Program
The Kentucky Pharmacy Education and Research Foundation (KPERF) annual Incentive Grant applications are now open. This year we will be awarding one $3,000 grant and two $1,000 grants to be used for projects and initiatives aimed towards advancing patient-centered care by pharmacists and innovative pharmacy practice. The grants were established to provide financial support for research, education, and promotion of innovative pharmacy practice initiatives with a focus on patient-centered services within the state of Kentucky.
Applications will remain open through Friday, September 15, 2023. Curious about last year's Incentive Grant Awardees? Here is a glimpse of their projects. All 2022 award recipients were also invited to present their research at this year's Annual Meeting during the Grand Rounds Session.
Frequently Asked Questions answered by Executive Fellow in this video and PowerPoint presentation!
Topics of Interest
- Kentucky Board-authorized protocols
- Chronic disease prevention and management (Diabetes care, smoking cessation, mental and behavioral health)
- Covid-19 Prevention/Treatment/Testing
- Credentialing and Medical Billing (House Bill 48)
- Harm Reduction (Drug take back, patient or provider education)
- Patient Care Service Implementation
- Pharmacist-Patient Communication
- Point of care testing
- Social Determinants of Health Factors and Community Engagement
- Transitions of Care
- Pharmacy Workplace Conditions
- Immunization Services
- July 24 – Application opens.
- September 15 – Application deadline.
- September – Review of applications by KPERF review committee.
- Early October – Notification of all grant applicants.
- Late October – Upon receipt of the Acceptance Agreement and W-9 forms, recipients will receive grant funding.
- March – Interim check-in due March 15, 2024.
- June 6 – 9 – Present poster report at KPhA Annual Meeting in Louisville, KY.
- June 30 – Final reports due, including final expense report.
- Applicants may be student pharmacists, pharmacy residents, pharmacy technicians, or pharmacists. If a student pharmacist or pharmacy technician is submitting this request, a faculty or pharmacist member must be a co-primary applicant.
- Applicants’ and co-primary applicants’ primary practice site must be physically located in Kentucky.
- Applicants and co-primary applicants must be current members of KPhA at the time of application and continue through as members to grant completion.
- Submit completed application with complete proposal to KPERF by the stated deadline.
- Grant recipients must participate in an interim check-in with a member of the Foundation staff to provide updates on project by March 15th, 2024.
- The results are to be provided in the form of a poster or platform presentation at the KPhA Annual Meeting June 6-9, 2024.
- The grant applicant must submit a final report to the Foundation indicating the specific outcomes by June 30th, 2024.
Appropriate Use of Grant Funds
Full payments will be made upon receipt of the completed Grant Acceptance/Agreement forms. Grant funds may be used only for direct costs associated with the development and implementation of the project described in the application. Expenditures for indirect costs (overhead) will not be funded. Salaries for recipients will not be allowed; however, consultant fees, fees for research/technician services and expenses for administrative services may be allowed if submitted in the proposed budget to the KPERF. Travel expenses and conference fees will not be funded. Monies may be used for reasonable printing costs relative to materials used for the project. Funding through and from other sources is permitted. Projects and related reports must recognize the Kentucky Pharmacy Education & Research Foundation (KPERF) as a grantor.
Final expense reports must be submitted once the project has ended. Reports shall include funding descriptions, vendors, dates of issue and any other relevant information.
The application process requires the submission of the application document and a detailed proposal with appropriate attachments as outlined below. Please upload the application and proposal in PDF format as one document, if possible.
Maximum of three (3) typewritten pages in Times New Roman, 11-point font, and 1.5 lines spacing addressing the following:
- General project description (please include how you believe this will advance the practice of pharmacy)
- Project objectives
- Methods to be utilized
- Evaluation strategy
- Timetable for the project
- Budget – Include total project budget outlining specific funds being requested for this grant.
- Projected utilization of any data or outcomes. In other words – the point or purpose of the project or study.
Applications are to be submitted electronically and must be received by Friday, September 15, 2023. Electronic submissions shall be submitted to Taylor Williams, Executive Fellow, at email@example.com with the subject line of “Incentive Grant Application”. The Foundation will NOT accept faxed or mailed submissions. Applications should be submitted in one PDF document, if possible.
All submissions will receive a confirmation receipt. It is the responsibility of the applicant to verify such receipt. Applicants that do not receive confirmation of receipt within 72 hours of submission have the obligation to follow-up to assure there was not an email issue and that the application was, in fact, received.
Grant submissions will be initially reviewed by the Grant Review Committee of the Board of Directors of the Kentucky Pharmacy Education & Research Foundation and will consider the following criteria.
- KPhA Membership of primary applicant and co-primary applicant
- Completeness of application and proposal
- Significance of the project
- Clarity of project objectives
- Project design
- Adequacy of resources available to complete the project
- Evaluation strategy and intended outcomes
- Reasonableness of budget
- Probability of completing the project
- Utilization of resulting data or outcomes or purpose of study/project
A copy of the form that the Reviewers will utilize is available here.
Final awardees will be confirmed by the Foundation’s Board of Directors. All members of the KPERF Board, including the Grant Review Committee must disclose any potential relationships or conflicts of interest with any potential awardees and if deemed relative, must recuse themselves from the grant evaluation and approval process. Members of the Kentucky Pharmacy Education & Research Foundation Board of Directors are not eligible to be applicants, co-applicants, or co-investigators on any grant submissions.
Award Presentation, Timetable, and Payment
Successful awardees will be notified no later than October 2nd, 2023. Full payments will be made upon receipt of the completed Grant Acceptance/Agreement forms and signed by the awardee, following this initial announcement of the grant award. Applicants that are not selected will also receive notice on or around the same time. This notice will include a brief explanation regarding why the grant was not selected.
Awards will be formally announced at the Kentucky Pharmacists Association Fall Conference October 20-21, 2023 in Lexington, Kentucky. While not required, the Foundation encourages successful recipients to be present for this recognition.
Please direct any further questions to Clark Kebodeaux, Chair of the Kentucky Pharmacy Education & Research Foundation (KPERF) at firstname.lastname@example.org or to Taylor Williams, Executive Fellow, at email@example.com.
2022-2023 Incentive Grant Recipients
COVID-19 Test Result Evaluation and Treatment (TREAT): A Pharmacy-Based Pilot Implementation Study
Primary Investigator: Dr. Dustin Miracle
Co-Investigator(s): Dr. Trish Freeman
Detecting Hypertension – Pharmacy Detection and Counseling Outcomes
Primary Investigator: Dr. Jesica Mills
Co-Investigator(s): Daisy Thomason & Ernest Mills
Clinic-Based and Community-Based Pharmacy Collaboration to Improve Hypertension Control (CACC-HTN)
Primary Investigator: Dr. MacKenzie Firek
Co-Investigator(s): Drs. Brooke Hudspeth, Melody Turpin, Corey Allen, Aric Schadlet, and Clark Kebodeaux
Implementation of a Pharmacogenomic Testing Service in an Independent Community Pharmacy and Its Impact on Medication Optimization
Primary Investigator: Dr. Nicholas Hudson
Co-Investigator(s): Drs. Adam Robinson, Brooke Hudspeth, Scott King, Jamie Wilkey, & NP Holly-Schultz-Pollock